High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Statins reduce the incidence of strokes among patients at increased risk for cardiovascular disease; whether they reduce the risk of stroke after a recent stroke or transient ischemic attack (TIA) remains to be established. METHODS: We randomly assigned 4731 patients who had had a stroke or TIA within one to six months before study entry, had low-density lipoprotein (LDL) cholesterol levels of 100 to 190 mg per deciliter (2.6 to 4.9 mmol per liter), and had no known coronary heart disease to double-blind treatment with 80 mg of atorvastatin per day or placebo. The primary end point was a first nonfatal or fatal stroke. RESULTS: The mean LDL cholesterol level during the trial was 73 mg per deciliter (1.9 mmol per liter) among patients receiving atorvastatin and 129 mg per deciliter (3.3 mmol per liter) among patients receiving placebo. During a median follow-up of 4.9 years, 265 patients (11.2 percent) receiving atorvastatin and 311 patients (13.1 percent) receiving placebo had a fatal or nonfatal stroke (5-year absolute reduction in risk, 2.2 percent; adjusted hazard ratio, 0.84; 95 percent confidence interval, 0.71 to 0.99; P=0.03; unadjusted P=0.05). The atorvastatin group had 218 ischemic strokes and 55 hemorrhagic strokes, whereas the placebo group had 274 ischemic strokes and 33 hemorrhagic strokes. The five-year absolute reduction in the risk of major cardiovascular events was 3.5 percent (hazard ratio, 0.80; 95 percent confidence interval, 0.69 to 0.92; P=0.002). The overall mortality rate was similar, with 216 deaths in the atorvastatin group and 211 deaths in the placebo group (P=0.98), as were the rates of serious adverse events. Elevated liver enzyme values were more common in patients taking atorvastatin. CONCLUSIONS: In patients with recent stroke or TIA and without known coronary heart disease, 80 mg of atorvastatin per day reduced the overall incidence of strokes and of cardiovascular events, despite a small increase in the incidence of hemorrhagic stroke. (ClinicalTrials.gov number, NCT00147602 [ClinicalTrials.gov].).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the recently published Lipitor's Effect in Alzheimer's Dementia (LEADe) trial, which included 640 randomized patients with mild Alzheimer disease, intensive lipid lowering by the addition of atorvastatin (80 mg) to donepezil did not improve cognitive function over a 72-week period.464”
In the citing paper
“Data from RCTs and meta-analyses indicate that routine early use of high-intensity statin therapy is associated with rapid and sustained clinical benefits [438-442].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [438]
In the citing paper
“Following stroke or TIA, 34 patients are at risk not only of recurrent cerebrovascular events but also of other major CV events including MI.”
From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [34]
In the citing paper
“Secondary prevention therapy with statins reduces the risk of recurrent stroke (by 12%), MI and vascular death.422,428”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [428]
In the citing paper
“Many reports have also indicated that there is no clear relationship between the TG level and cerebrovascular disease856, 862, 863).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [862]
Citations
Cites
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Sever, P. S., Dahlöf, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12948-0 · Cited by 3,782
Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., W Neil, H. A., Livingstone, S. J., Thomason, M. J., Mackness, M. I., Charlton-Menys, V., & Fuller, J. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16895-5 · Cited by 3,755
Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis
Rankin, J. (1957) · Scottish Medical Journal · doi:10.1177/003693305700200504 · Cited by 2,506
Sacco, R. L., Adams, R., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., et al. (2006) · Stroke · doi:10.1161/01.str.0000199147.30016.74 · Cited by 1,873
Iso, H., Jacobs, D. R., Wentworth, D., Neaton, J. D., Cohen, J. D., & for the MRFIT Research Group* (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201405 · Cited by 1,133
Amarenco, P., Labreuche, J., Lavallée, P., & Touboul, P.-J. (2004) · Stroke · doi:10.1161/01.str.0000147965.52712.fa · Cited by 746
Research works printed but not linked: 1
- Waters DD, 2005, Circulation, 112, 2020
Cited by
Items 101–200 of 1,005
Risk Factors for Intracerebral Hemorrhage in a Pooled Prospective Study
Sturgeon, J. D., Folsom, A. R., Longstreth, W. T., Shahar, E., Rosamond, W. D., & Cushman, M. (2007) · Stroke · doi:10.1161/strokeaha.107.487090 · Cited by 364
Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage
Diener, H.-C., & Hankey, G. J. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.072 · Cited by 364
Vascular cognitive impairment: current concepts and clinical developments
Moorhouse, P., & Rockwood, K. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70040-1 · Cited by 358
Cholesterol Treatment Trialists' (CTT) Collaboration (2012) · PLoS ONE · doi:10.1371/journal.pone.0029849 · Cited by 351
Peripheral Artery Disease: Current Insight Into the Disease and Its Diagnosis and Management
Olin, J. W., & Sealove, B. A. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0133 · Cited by 349
Grundy, S. M. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.10.001 · Cited by 347
Amarenco, P., Goldstein, L. B., Szarek, M., Sillesen, H., Rudolph, A. E., Callahan, A., Hennerici, M., Simunovic, L., Zivin, J. A., & Welch, K. M. A. (2007) · Stroke · doi:10.1161/strokeaha.107.493106 · Cited by 343
Mills, E. J., WU, P., Chong, G., Ghement, I., Singh, S., Akl, E. A., Eyawo, O., Guyatt, G., Berwanger, O., & Briel, M. (2011) · QJM · doi:10.1093/qjmed/hcq165 · Cited by 338
(2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30156-5 · Cited by 338
Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin
Waters, D. D., Ho, J. E., DeMicco, D. A., Breazna, A., Arsenault, B. J., Wun, C.-C., Kastelein, J. J., Colhoun, H., & Barter, P. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.10.047 · Cited by 333
Relationship between Hyperlipidemia, Cardiovascular Disease and Stroke: A Systematic Review
Alloubani, A., Nimer, R., & Samara, R. (2021) · Current Cardiology Reviews · doi:10.2174/1573403x16999201210200342 · Cited by 314
Statin treatment withdrawal in ischemic stroke: A controlled randomized study
Blanco, M., Nombela, F., Castellanos, M., Rodriguez-Yáñez, M., García-Gil, M., Leira, R., Lizasoain, I., Serena, J., Vivancos, J., Moro, M. A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000269789.09277.47 · Cited by 330
Li, Q., Yang, Y., Reis, C., Tao, T., Li, W., Li, X., & Zhang, J. H. (2018) · Cell Transplantation · doi:10.1177/0963689718795148 · Cited by 320
Grundy, S. M., Arai, H., Barter, P., Bersot, T. P., Betteridge, D. J., Carmena, R., Cuevas, A., Davidson, M. H., Genest, J., Kesäniemi, Y. A., et al. (2014) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.12.005 · Cited by 327
Drug‐screening platform based on the contractility of tissue‐engineered muscle
Vandenburgh, H., Shansky, J., Benesch‐Lee, F., Barbata, V., Reid, J., Thorrez, L., Valentini, R., & Crawford, G. (2008) · Muscle & Nerve · doi:10.1002/mus.20931 · Cited by 316
on behalf of the China Kadoorie Biobank Collaborative Group, Sun, L., International Steering Committee, International Co-ordinating Centre, O., National Co-ordinating Centre, B., Centres, R. C.-O., Clarke, R., Bennett, D., Guo, Y., Walters, R. G., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0366-x · Cited by 318
Statins in the primary prevention of cardiovascular disease
Reiner, Ž. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.80 · Cited by 189
ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on Carotid Stenting
Bates, E. R., Babb, J. D., Casey, D. E., Cates, C. U., Duckwiler, G. R., Feldman, T. E., Gray, W. A., Ouriel, K., Peterson, E. D., Rosenfield, K., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.021 · Cited by 310
Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus
Navarese, E. P., Buffon, A., Andreotti, F., Kozinski, M., Welton, N., Fabiszak, T., Caputo, S., Grzesk, G., Kubica, A., Swiatkiewicz, I., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.12.037 · Cited by 308
Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 302
HEMORRHAGIC STROKE IN THE STROKE PREVENTION BY AGGRESSIVE REDUCTION IN CHOLESTEROL LEVELS STUDY
Vergouwen, M. D. I., Vermeulen, M., & Roos, Y. B. W. E. M. (2009) · Neurology · doi:10.1212/01.wnl.0000346744.56398.e5 · Cited by 303
McKinney, J. S., & Kostis, W. J. (2012) · Stroke · doi:10.1161/strokeaha.112.655894 · Cited by 294
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection
Tsan, Y.-T., Lee, C.-H., Wang, J.-D., & Chen, P.-C. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.0917 · Cited by 294
Jiang, R., Zhao, S., Wang, R., Feng, H., Zhang, J., Li, X., Mao, Y., Yuan, X., Fei, Z., Zhao, Y., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.2030 · Cited by 283
Kaasenbrood, L., Boekholdt, S. M., van der Graaf, Y., Ray, K. K., Peters, R. J. G., Kastelein, J. J. P., Amarenco, P., LaRosa, J. C., Cramer, M. J. M., Westerink, J., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.021314 · Cited by 279
Sillesen, H., Amarenco, P., Hennerici, M. G., Callahan, A., Goldstein, L. B., Zivin, J., Messig, M., & Welch, K. M. (2008) · Stroke · doi:10.1161/strokeaha.108.516450 · Cited by 277
Recognition and management of stroke in young adults and adolescents
Singhal, A. B., Biller, J., Elkind, M. S., Fullerton, H. J., Jauch, E. C., Kittner, S. J., Levine, D. A., & Levine, S. R. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a4a451 · Cited by 277
The Primary Outcome Fails — What Next?
Pocock, S. J., & Stone, G. W. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1510064 · Cited by 274
Amarenco, P., Benavente, O., Goldstein, L. B., Callahan, A., Sillesen, H., Hennerici, M. G., Gilbert, S., Rudolph, A. E., Simunovic, L., Zivin, J. A., et al. (2009) · Stroke · doi:10.1161/strokeaha.108.534107 · Cited by 271
Lee, H.-Y., Shin, J., Kim, G.-H., Park, S., Ihm, S.-H., Kim, H. C., Kim, K.-I., Kim, J. H., Lee, J. H., Park, J.-M., et al. (2019) · Clinical Hypertension · doi:10.1186/s40885-019-0124-x · Cited by 264
Danaei, G., Tavakkoli, M., & Hernán, M. A. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr301 · Cited by 264
Reith, C., Baigent, C., Blackwell, L., Emberson, J., Spata, E., Davies, K., Halls, H., Holland, L., Wilson, K., Armitage, J., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01545-8 · Cited by 264
Huang, Y., Cheng, Y., Wu, J., Li, Y., Xu, E., Hong, Z., Li, Z., Zhang, W., Ding, M., Gao, X., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70094-2 · Cited by 263
Post‐stroke cognitive decline: an update and perspectives for clinical research
Brainin, M., Tuomilehto, J., Heiss, W. ‐., Bornstein, N. M., Bath, P. M. W., Teuschl, Y., Richard, E., Guekht, A., Quinn, T., & the Post Stroke Cognition Study Group (2015) · European Journal of Neurology · doi:10.1111/ene.12626 · Cited by 253
A systematic review of statin-induced muscle problems in clinical trials
Ganga, H. V., Slim, H. B., & Thompson, P. D. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.03.019 · Cited by 253
Brott, T. G., Halperin, J. L., Abbara, S., Bacharach, J. M., Barr, J. D., Bush, R. L., Cates, C. U., Creager, M. A., Fowler, S. B., Friday, G., et al. (2013) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.22983 · Cited by 253
“The metabolic syndrome (defined by the World Health Organization and the National Cholesterol Education Program on the basis of blood glucose, hypertension, dyslipidemia, body mass index, waist/hip ratio, and urinary albumin excretion) is associated with carotid atherosclerosis after adjustment for other risk factors.…”
InfluentialKoskinas, K. C., Siontis, G. C. M., Piccolo, R., Mavridis, D., Räber, L., Mach, F., & Windecker, S. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx566 · Cited by 252
Lipid levels and the risk of ischemic stroke in women
Kurth, T., Everett, B. M., Buring, J. E., Kase, C. S., Ridker, P. M., & Gaziano, J. M. (2007) · Neurology · doi:10.1212/01.wnl.0000254472.41810.0d · Cited by 248
Association of Aspirin Use With Major Bleeding in Patients With and Without Diabetes
De Berardis, G., Lucisano, G., D’Ettorre, A., Pellegrini, F., Lepore, V., Tognoni, G., & Nicolucci, A. (2012) · JAMA · doi:10.1001/jama.2012.5034 · Cited by 246
Neurological complications of acute ischaemic stroke
Balami, J. S., Chen, R.-L., Grunwald, I. Q., & Buchan, A. M. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70313-6 · Cited by 246
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia
Blumenthal, R. S., Morris, P. B., Gaudino, M., Johnson, H. M., Anderson, T. S., Bittner, V. A., Blankstein, R., Brewer, L. C., Cho, L., de Ferranti, S. D., et al. (2026) · JACC · doi:10.1016/j.jacc.2025.11.016 · Cited by 304
The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice
Banerjee, G., Carare, R., Cordonnier, C., Greenberg, S. M., Schneider, J. A., Smith, E. E., Buchem, M. V., Grond, J. V. D., Verbeek, M. M., & Werring, D. J. (2017) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-314697 · Cited by 240
Posterior circulation ischaemic stroke
Merwick, A., & Werring, D. (2014) · BMJ · doi:10.1136/bmj.g3175 · Cited by 232
Lipid lowering with PCSK9 inhibitors
Dadu, R. T., & Ballantyne, C. M. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.84 · Cited by 237
Statins for the treatment of dementia
McGuinness, B., Craig, D., Bullock, R., Malouf, R., & Passmore, P. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007514.pub3 · Cited by 216
Ní Chróinín, D., Asplund, K., Åsberg, S., Callaly, E., Cuadrado-Godia, E., Díez-Tejedor, E., Di Napoli, M., Engelter, S. T., Furie, K. L., Giannopoulos, S., et al. (2013) · Stroke · doi:10.1161/strokeaha.112.668277 · Cited by 234
Dawson, J., Béjot, Y., Christensen, L. M., De Marchis, G. M., Dichgans, M., Hagberg, G., Heldner, M. R., Milionis, H., Li, L., Pezzella, F. R., et al. (2022) · European Stroke Journal · doi:10.1177/23969873221100032 · Cited by 226
Amarenco, P., Labreuche, J., & Touboul, P.-J. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.07.033 · Cited by 232
“Moreover, in patients who had already had a stroke or cerebral transient ischemic attack, the Stroke Prevention y Aggressive Reduction in Cholesterol Levels (SPARCL) rial showed that lowering LDL-C reduced the risk of having nother stroke or a revascularization procedure, includng carotid endarterectomy [6,7].”
BackgroundIntracranial Atherosclerosis: Current Understanding and Perspectives
Bang, O. Y. (2014) · Journal of Stroke · doi:10.5853/jos.2014.16.1.27 · Cited by 229
Cardiovascular risk factors and dementia
Fillit, H., Nash, D. T., Rundek, T., & Zuckerman, A. (2008) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2008.06.004 · Cited by 225
Anti-Inflammatory Targets for the Treatment of Reperfusion Injury in Stroke
Mizuma, A., & Yenari, M. A. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00467 · Cited by 225
2023 Chinese guideline for lipid management
Li, J.-J., Zhao, S.-P., Zhao, D., Lu, G.-P., Peng, D.-Q., Liu, J., Chen, Z.-Y., Guo, Y.-L., Wu, N.-Q., Yan, S.-K., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1190934 · Cited by 223
Pioglitazone: the forgotten, cost-effective cardioprotective drug for type 2 diabetes
DeFronzo, R. A., Inzucchi, S., Abdul-Ghani, M., & Nissen, S. E. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118825376 · Cited by 223
Inflammation and Stroke Risk: A New Target for Prevention
Kelly, P. J., Lemmens, R., & Tsivgoulis, G. (2021) · Stroke · doi:10.1161/strokeaha.121.034388 · Cited by 216
Disorders of lipid metabolism. Clinical Guidelines 2023
Ezhov, M. V., Kukharchuk, V. V., Sergienko, I. V., Alieva, A. S., Antsiferov, M. B., Ansheles, A. A., Arabidze, G. G., Aronov, D. M., Arutyunov, G. P., Akhmedzhanov, N. M., et al. (2023) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2023-5471 · Cited by 219
Fleg, J. L., Forman, D. E., Berra, K., Bittner, V., Blumenthal, J. A., Chen, M. A., Cheng, S., Kitzman, D. W., Maurer, M. S., Rich, M. W., et al. (2013) · Circulation · doi:10.1161/01.cir.0000436752.99896.22 · Cited by 219
Caprio, F. Z., & Sorond, F. A. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.10.001 · Cited by 219
Tanaka, K., Ishikawa, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Saito, Y., Matsuzawa, Y., Sasaki, J., Oikawa, S., Hishida, H., et al. (2008) · Stroke · doi:10.1161/strokeaha.107.509455 · Cited by 217
2018 Guidelines for the management of dyslipidemia
Rhee, E.-J., Kim, H. C., Kim, J. H., Lee, E. Y., Kim, B. J., Kim, E. M., Song, Y., Lim, J. H., Kim, H. J., Choi, S., et al. (2019) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2019.188 · Cited by 213
Liu, L., Li, Z., Zhou, H., Duan, W., Huo, X., Xu, W., Li, S., Nie, X., Liu, H., Liu, J., et al. (2023) · Stroke and Vascular Neurology · doi:10.1136/svn-2023-002998 · Cited by 199
Naci, H., Brugts, J. J., Fleurence, R., Tsoi, B., Toor, H., & Ades, A. (2013) · European Journal of Preventive Cardiology · doi:10.1177/2047487313480435 · Cited by 202
Statins as Antithrombotic Drugs
Violi, F., Calvieri, C., Ferro, D., & Pignatelli, P. (2013) · Circulation · doi:10.1161/circulationaha.112.145334 · Cited by 205
Aortic Arch Plaques and Risk of Recurrent Stroke and Death
Di Tullio, M. R., Russo, C., Jin, Z., Sacco, R. L., Mohr, J. P., & Homma, S. (2009) · Circulation · doi:10.1161/circulationaha.108.811935 · Cited by 206
Statin‐Associated Adverse Cognitive Effects: Survey Results from 171 Patients
Evans, M. A., & Golomb, B. A. (2009) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.7.800 · Cited by 204
Giugliano, R. P., Wiviott, S. D., Blazing, M. A., De Ferrari, G. M., Park, J.-G., Murphy, S. A., White, J. A., Tershakovec, A. M., Cannon, C. P., & Braunwald, E. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.0083 · Cited by 205
The Acute Management of Intracerebral Hemorrhage: A Clinical Review
Elliott, J., & Smith, M. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181d568c8 · Cited by 202
Cognitive and Behavioral Neurology
Finger, E., & Daffner, K. R. (2012) · Neurology · doi:10.1007/978-0-387-88555-1_8 · Cited by 200
Statins, incident Alzheimer disease, change in cognitive function, and neuropathology
Arvanitakis, Z., Schneider, J. A., Wilson, R. S., Bienias, J. L., Kelly, J. F., Evans, D. A., & Bennett, D. A. (2008) · Neurology · doi:10.1212/01.wnl.0000288181.00826.63 · Cited by 199
Statin non-adherence and residual cardiovascular risk: There is need for substantial improvement
Banach, M., Stulc, T., Dent, R., & Toth, P. P. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.09.075 · Cited by 197
Bartels, K., Karhausen, J., Clambey, E. T., Grenz, A., & Eltzschig, H. K. (2013) · Anesthesiology · doi:10.1097/aln.0000000000000022 · Cited by 196
Boekholdt, S. M., Arsenault, B. J., Hovingh, G. K., Mora, S., Pedersen, T. R., LaRosa, J. C., Welch, K. M. A., Amarenco, P., DeMicco, D. A., Tonkin, A. M., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.002670 · Cited by 196
Clopidogrel Plus Aspirin Versus Warfarin in Patients With Stroke and Aortic Arch Plaques
Amarenco, P., Davis, S., Jones, E. F., Cohen, A. A., Heiss, W.-D., Kaste, M., Laouénan, C., Young, D., Macleod, M., Donnan, G. A., et al. (2014) · Stroke · doi:10.1161/strokeaha.113.004251 · Cited by 197
Rosenzweig, J. L., Ferrannini, E., Grundy, S. M., Haffner, S. M., Heine, R. J., Horton, E. S., & Kawamori, R. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0222 · Cited by 194
Amarenco, P., Albers, G. W., Denison, H., Easton, J. D., Evans, S. R., Held, P., Hill, M. D., Jonasson, J., Kasner, S. E., Ladenvall, P., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30038-8 · Cited by 198
AbuRahma, A. F., Avgerinos, E. D., Chang, R. W., Darling, R. C., Duncan, A. A., Forbes, T. L., Malas, M. B., Perler, B. A., Powell, R. J., Rockman, C. B., et al. (2022) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2021.04.074 · Cited by 190
ESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.012 · Cited by 192
Statins for the prevention of dementia
McGuinness, B., Craig, D., Bullock, R., & Passmore, P. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003160.pub2 · Cited by 193
2018 Guidelines for the Management of Dyslipidemia in Korea
Rhee, E.-J., Kim, H. C., Kim, J. H., Lee, E. Y., Kim, B. J., Kim, E. M., Song, Y., Lim, J. H., Kim, H. J., Choi, S., et al. (2019) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2019.8.2.78 · Cited by 192
Tong, T. Y. N., Appleby, P. N., Bradbury, K. E., Perez-Cornago, A., Travis, R. C., Clarke, R., & Key, T. J. (2019) · BMJ · doi:10.1136/bmj.l4897 · Cited by 190
Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation
Abela, G. S. (2010) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2010.03.003 · Cited by 188
Hindy, G., Engström, G., Larsson, S. C., Traylor, M., Markus, H. S., Melander, O., & Orho-Melander, M. (2018) · Stroke · doi:10.1161/strokeaha.117.019653 · Cited by 186
Wang, N., Fulcher, J., Abeysuriya, N., Park, L., Kumar, S., Di Tanna, G. L., Wilcox, I., Keech, A., Rodgers, A., & Lal, S. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30388-2 · Cited by 187
Chatzizisis, Y. S., Koskinas, K. C., Misirli, G., Vaklavas, C., Hatzitolios, A., & Giannoglou, G. D. (2010) · Drug Safety · doi:10.2165/11319380-000000000-00000 · Cited by 187
Statins and Intracerebral Hemorrhage: Collaborative Systematic Review and Meta-Analysis
Hackam, D. G., Woodward, M., Newby, L. K., Bhatt, D. L., Shao, M., Smith, E. E., Donner, A., Mamdani, M., Douketis, J. D., Arima, H., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.055269 · Cited by 187
Statin Therapy in the Prevention of Recurrent Cardiovascular Events: A Sex-Based Meta-analysis
Gutierrez, J., Ramirez, G., Rundek, T., & Sacco, R. L. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.2145 · Cited by 185
Rothwell, P. M., Algra, A., & Amarenco, P. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60516-3 · Cited by 185
Giugliano, R. P., Pedersen, T. R., Saver, J. L., Sever, P. S., Keech, A. C., Bohula, E. A., Murphy, S. A., Wasserman, S. M., Honarpour, N., Wang, H., et al. (2020) · Stroke · doi:10.1161/strokeaha.119.027759 · Cited by 184
Symptomatic and asymptomatic carotid artery plaque
Mughal, M. M., Khan, M. K., DeMarco, J. K., Majid, A., Shamoun, F., & Abela, G. S. (2011) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.120 · Cited by 184
Prevalence of Coronary Atherosclerosis in Patients With Cerebral Infarction
Amarenco, P., Lavallée, P. C., Labreuche, J., Ducrocq, G., Juliard, J.-M., Feldman, L., Cabrejo, L., Meseguer, E., Guidoux, C., Adraï, V., et al. (2011) · Stroke · doi:10.1161/strokeaha.110.584086 · Cited by 186
Statin Therapy in Stroke Prevention: A Meta-analysis Involving 121,000 Patients
O’Regan, C., Wu, P., Arora, P., Perri, D., & Mills, E. J. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.06.033 · Cited by 182
Diabetes, the Metabolic Syndrome, and Ischemic Stroke
Air, E. L., & Kissela, B. M. (2007) · Diabetes Care · doi:10.2337/dc06-1537 · Cited by 180
Secondary stroke prevention: challenges and solutions
Gutierrez, J., & Esenwa, C. (2015) · Vascular Health and Risk Management · doi:10.2147/vhrm.s63791 · Cited by 177
Lipids and Cerebrovascular Disease: Research and Practice
Yaghi, S., & Elkind, M. S. V. (2015) · Stroke · doi:10.1161/strokeaha.115.011164 · Cited by 176
MRI of carotid atherosclerosis: clinical implications and future directions
Underhill, H. R., Hatsukami, T. S., Fayad, Z. A., Fuster, V., & Yuan, C. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.246 · Cited by 175
Mancini, G. B. J., Tashakkor, A. Y., Baker, S., Bergeron, J., Fitchett, D., Frohlich, J., Genest, J., Gupta, M., Hegele, R. A., Ng, D. S., et al. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.09.023 · Cited by 173
Newman, C. B., Blaha, M. J., Boord, J. B., Cariou, B., Chait, A., Fein, H. G., Ginsberg, H. N., Goldberg, I. J., Murad, M. H., Subramanian, S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa674 · Cited by 172
Discontinuation of Statin Therapy and Clinical Outcome After Ischemic Stroke
Colivicchi, F., Bassi, A., Santini, M., & Caltagirone, C. (2007) · Stroke · doi:10.1161/strokeaha.107.487017 · Cited by 174
Risk factor status and vascular events in patients with symptomatic intracranial stenosis
Chaturvedi, S., Turan, T. N., Lynn, M. J., Kasner, S. E., Romano, J., Cotsonis, G., Frankel, M., & Chimowitz, M. I. (2007) · Neurology · doi:10.1212/01.wnl.0000279338.18776.26 · Cited by 174
Writing Committee Members, Brott, T. G., Halperin, J. L., Abbara, S., Bacharach, J. M., Barr, J. D., Bush, R. L., Cates, C. U., Creager, M. A., Fowler, S. B., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182112cc2 · Cited by 174
Metadata
- Authors
- The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators
- Affiliations
- Université Paris Diderot (FR)
- Corresponding author
- The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-08-10
- Volume
- 355
- Issue
- 6
- Pages
- 549-559
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1546258268
- Cited by
- 2,887
- References
- 21
- Citations by year
- 2026: 86 · 2025: 96 · 2024: 119 · 2023: 112 · 2022: 135 · 2021: 134 · 2020: 139 · 2019: 140 · 2018: 129 · 2017: 132 · 2016: 139 · 2015: 125 · 2014: 142 · 2013: 160 · 2012: 149
- FWCI
- 200.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Eisai
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cerebrovascular and Carotid Artery Diseases
- Keywords
- atorvastatin, high-intensity statin therapy, stroke, transient ischemic attack, secondary stroke prevention, LDL cholesterol lowering, hemorrhagic stroke, ischemic stroke, cardiovascular events, elevated liver enzymes, lipid-lowering therapy, mortality, serious adverse events
- MeSH terms
- Atorvastatin, Adult, Cardiovascular Diseases, Cerebral Hemorrhage, Cerebral Infarction, Ischemic Attack, Transient, Drug Therapy, Combination, Female, Heptanoic Acids, Humans, Cholesterol, LDL, Male, Pyrroles, Risk, Proportional Hazards Models, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Stroke, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.